From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000009:adverse effects*; D016000:Cluster Analysis; D015331:Cohort Studies; D004917:Erythromycin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006984:Hypertrophy; D007223:Infant; D007231:Infant, Newborn; D017757:Infectious Disease Transmission, Professional-to-Patient; D011707:Pyloric Stenosis / Q000139:chemically induced* / Q000453:epidemiology*; D013714:Tennessee / Q000453:epidemiology; D014917:Whooping Cough / Q000517:prevention & control* / Q000635:transmission
D000900:Anti-Bacterial Agents; D004917:Erythromycin